Sabra Healthcare REIT (NASDAQ:SBRA) Stock Picked Up by Analysts at Huntington Sec

Huntington Sec began coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a research note issued on Monday, Zacks reports. The firm set a “strong-buy” rating on the real estate investment trust’s stock.

Other equities research analysts have also issued research reports about the company. Citizens Jmp boosted their target price on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research note on Wednesday, July 22nd. UBS Group reduced their price target on Sabra Healthcare REIT from $21.00 to $20.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 13th. Mizuho set a $21.00 price target on Sabra Healthcare REIT in a research note on Monday, August 31st. Robert W. Baird boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Monday, August 31st. Finally, Weiss Ratings raised Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $21.50.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $20.35 on Monday. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The company has a market capitalization of $5.20 billion, a PE ratio of 72.68, a P/E/G ratio of 1.79 and a beta of 0.68. The firm has a fifty day simple moving average of $19.85 and a two-hundred day simple moving average of $19.97. Sabra Healthcare REIT has a twelve month low of $17.53 and a twelve month high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.56%. The business had revenue of $249.57 million for the quarter, compared to analysts’ expectations of $236.64 million. During the same quarter in the previous year, the company earned $0.38 earnings per share. The business’s quarterly revenue was up 31.4% on a year-over-year basis. Research analysts expect that Sabra Healthcare REIT will post 1.52 EPS for the current year.

Insider Activity

In other news, CEO Richard Matros sold 200,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Versant Capital Management Inc raised its position in Sabra Healthcare REIT by 70.0% during the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares during the last quarter. Root Financial Partners LLC bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth approximately $34,000. Heritage Family Offices LLP bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth approximately $45,000. Mather Group LLC. grew its position in shares of Sabra Healthcare REIT by 34,550.0% in the 3rd quarter. Mather Group LLC. now owns 2,772 shares of the real estate investment trust’s stock worth $55,000 after buying an additional 2,764 shares during the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new position in shares of Sabra Healthcare REIT during the second quarter valued at approximately $61,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

More Sabra Healthcare REIT News

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 guidance: EPS is now projected at $1.54–$1.55, above the $1.52 consensus, and the midpoint of normalized FFO guidance increased by $0.005 per share. Management also expects 7%–8% year-over-year earnings growth. Sabra Health Care: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Third-quarter revenue of about $249.6 million exceeded analyst estimates of $236.6 million and rose 31.4% year over year. Adjusted FFO also topped consensus, according to Zacks. Sabra Healthcare Tops Q3 FFO and Revenue Estimates
• Positive Sentiment: Senior-housing operating portfolio occupancy reached 89.2%, supporting the company’s growth outlook. Sabra also declared a quarterly dividend of $0.30 per share, equivalent to a 6.0% yield based on the provided data. Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
• Neutral Sentiment: Sabra aims to increase its senior housing operating portfolio (SHOP) to 50% of its portfolio by year-end 2027, while management sees further upside from nursing-home asset optimization and lease negotiations. The strategy offers growth potential but depends on execution. Sabra Expects Earnings Growth and Targets More SHOP Exposure
• Negative Sentiment: Reported third-quarter net income was $0.11 per diluted share, below the $0.16 analyst consensus and down from $0.38 a year earlier. This earnings miss may temper the positive impact of stronger revenue, FFO, and guidance. Sabra Q3 Earnings Results

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.